As of May 2024 POINT Biopharma has a market cap of $1.33 Billion. This makes POINT Biopharma the world's 4754th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.33 B | 0% |
2023 | $1.33 B | 72.97% |
2022 | $0.77 B | 52.6% |
2021 | $0.50 B |